Note: This is sponsored content. The views expressed here are solely those of the author.

Array Technologies is upgraded to a 'Buy' as regulatory uncertainty eases, demand rebounds, and pricing stabilizes. Q3 bookings surged, driving the order book to $1.9B and signaling robust recovery in ...

Chris Wedel is a fan of all things tech and gadgets. Living in rural Kansas with his wife and two young boys makes finding ways to stay online tricky — not to mention making my homestead smarter.

The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $12.82 / share. This is an increase of 10.52% from the prior estimate of $11.60 dated November 14, 2025. The ...

A trio of weekend concerts by the Steamboat Symphony Orchestra will bring musical cheer to the Yampa Valley as the weather turns colder and the holiday season heats up. The orchestra will present ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the ...

while handling 'get_globals' implies to me that Thonny parses the contents of globals() after every line on the REPL executes for things like tab completion and viewing variables. That large array ...

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Defendants recklessly overstated the IGNYTE ...

Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...